alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 7,401–7,425 of 27,380 studies, newest first · page 297 of 1096.

September 2023 2

  1. 2023-09-01

    Vegetarian and vegan diets: benefits and drawbacks

    ✓ Peer-reviewed Prevention and risk European heart journal

    Key finding: Prospective studies suggest that consuming vegetarian diets is associated with a reduced risk of developing cardiovascular disease (CVD), diabetes, hypertension, dementia, and cancer.

    Full summary, score breakdown and related studies → Original source

  2. 2023-09-01

    Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies

    ✓ Peer-reviewed Treatments Neurology

    Key finding: In a proportion of patients, dementia with Lewy bodies (DLB) is associated with Alzheimer disease (AD) copathology, which is linked to accelerated cognitive decline and more extensive cortical atrophy. +4 more findings

    Full summary, score breakdown and related studies → Original source

August 2023 23

  1. 2023-08-31

    Crosstalk between NLRP3 inflammasome and calpain in Alzheimer's disease

    ✓ Peer-reviewed Inflammation and the immune system The European journal of neuroscience

    Key finding: Further, calpain hyperactivation is also associated with calcium homeostasis that acts as one of the triggers in the activation of NLRP3 inflammasome. +1 more finding

    Full summary, score breakdown and related studies → Original source

  2. 2023-08-31

    Stroke Prevention

    ✓ Peer-reviewed Prevention and risk Delaware journal of public health

    Key finding: In addition to stroke prevention, these strategies help with overall brain health, which may also have an impact on neurological degenerative diseases such as Alzheimer's disease.

    Full summary, score breakdown and related studies → Original source

  3. 2023-08-31

    Alzheimer's Disease: Causal Effect between Obesity and APOE Gene Polymorphisms

    ✓ Peer-reviewed Genetics International journal of molecular sciences

    Key finding: Bioinformatics analysis revealed Apolipoprotein E (APOE) as the key target of obesity-induced AD. +2 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2023-08-31

    Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia

    ✓ Peer-reviewed Digital health tools Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Overcoming these challenges will involve collecting data from underrepresented populations, developing more powerful AI approaches, validating the use of noninvasive biomarkers, and adhering to reporting guidelines. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2023-08-31

    A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases

    ✓ Peer-reviewed Biomarkers Nature Aging

    Key finding: Depending on whether lenient, moderate or stringent thresholds were used in step 1, the two-step workflow overall accuracy for detecting Aβ-PET status was 88.2%, 90.5% and 92.0%, respectively, while reducing the number of necessary CSF tests by 85.9%, 72.7% and 61.2%, respectively. +1 more finding

    Full summary, score breakdown and related studies → Original source

  6. 2023-08-30

    GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes

    ✓ Peer-reviewed Drug development Diabetes & metabolism

    Key finding: Glucagon-like peptide 1 (GLP-1) is a hormone of the incretin family, secreted in response to nutrient ingestion, and plays a role in metabolic homeostasis. +1 more finding

    Full summary, score breakdown and related studies → Original source

  7. 2023-08-30

    Amyloid-β (Aβ) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer's disease mice

    ✓ Peer-reviewed Treatments Molecular neurodegeneration

    Key finding: Our study establishes a connection between Aβ antibodies engaged at CAA deposits, the activation of perivascular macrophages, and the upregulation of genes involved in vascular permeability. +3 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2023-08-30

    Evaluation of Neighborhood-Level Disadvantage and Cognition in Mexican American and Non-Hispanic White Adults 50 Years and Older in the US

    ✓ Peer-reviewed Risk factors JAMA Network Open

    Key finding: Among 1614 older adults (mean [SD] age, 66.3 [8.7] years; 980 women [60.7%]), 853 were Mexican American (mean [SD] age, 63.9 [7.9] years; 566 women [66.4%]), and 761 were non-Hispanic White (mean [SD] age, 69.1 [8.7] years; 414 women [54.4%]). +4 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2023-08-29

    Microbiota-gut-brain axis and ketogenic diet: how close are we to tackling epilepsy?

    ✓ Peer-reviewed Disease mechanisms Microbiome research reports

    Key finding: This axis has been suggested to play a role in several neurological disorders, such as Parkinson's disease, Alzheimer's disease, multiple sclerosis, and epilepsy, paving the way for microbiome-based intervention strategies for the mitigation and treatment of symptoms. +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2023-08-29

    Key variants via Alzheimer's Disease Sequencing Project whole genome sequence data

    ✓ Peer-reviewed Genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Seventeen variants were significantly associated with AD within five genomic regions implicating the genes OARD1/NFYA/TREML1, JAZF1, FERMT2, and SLC24A4. +2 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2023-08-29

    Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet

    ✓ Peer-reviewed Treatments Neurology

    Key finding: Based on the results of the prespecified coprimary endpoints, this study was negative. +4 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2023-08-28

    α-Synuclein pathology in post-mortem retina and optic nerve is specific for α-synucleinopathies

    ✓ Peer-reviewed Brain tissue and pathology NPJ Parkinson's disease

    Key finding: Specific protein aggregates associated with neurodegenerative diseases are present in the retina and could be visualised in a non-invasive way. +1 more finding

    Full summary, score breakdown and related studies → Original source

  13. 2023-08-28

    Highly functionalized diaminocyclopentanes: A new route to potent and selective inhibitors of human O-GlcNAcase

    ✓ Peer-reviewed Drug development Bioorganic chemistry

    Key finding: A new class of compounds inhibiting de-O-glycosylation of proteins has been identified. +2 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2023-08-28

    Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Plasma p-tau217 may capture earlier Alzheimer's disease (AD)-related cognitive and brain atrophy hallmarks in females compared to males, possibly reflective of increased susceptibility to AD pathophysiology. +1 more finding

    Full summary, score breakdown and related studies → Original source

  15. 2023-08-25

    Vascular cognitive impairment - Past, present, and future challenges

    ✓ Peer-reviewed Vascular contributions Ageing research reviews

    Key finding: However, little is known about the pathological processes underlying VCI and the temporal dynamics between risk factors and disease mechanisms (biochemical and structural brain changes). +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2023-08-24

    Primary retinal tauopathy: A tauopathy with a distinct molecular pattern

    ✓ Peer-reviewed Risk factors Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Retinal p-tau pathology showed a consistent pattern with four stages and a molecular composition distinct from that of cerebral tauopathies. +3 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2023-08-24

    Obstructive sleep apnea and dementia: A role to play?

    ✓ Peer-reviewed Risk factors Revue neurologique

    Key finding: Among sleep disorders, obstructive sleep apnea (OSA) appears to be a potentially interesting comorbidity, as it is highly prevalent in the middle-aged and elderly population, often associated with some cognitive impairment, associated with an increased risk of developing cognitive decline and dementia including AD, and indeed treatable. +1 more finding

    Full summary, score breakdown and related studies → Original source

  18. 2023-08-24

    Racially fair pupillometry measurements for RGB smartphone cameras using the far red spectrum

    ✓ Peer-reviewed Cognitive tests and assessment Scientific reports

    Key finding: Prior work have demonstrated the potential for pupillometry in screening or diagnosing a number of neurological disorders including Alzheimer's Disease, Schizophrenia, and Traumatic Brain Injury.

    Full summary, score breakdown and related studies → Original source

  19. 2023-08-24

    Development of a three-dimensional organoid model to explore early retinal phenotypes associated with Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Scientific reports

    Key finding: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of Aβ plaques and neurofibrillary tangles, resulting in synaptic loss and neurodegeneration. +2 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2023-08-22

    HtrA1 prevents and reverses α-synuclein aggregation, rendering it non-toxic and seeding incompetent

    ✓ Peer-reviewed Brain tissue and pathology Nature communications

    Key finding: HtrA1 is a PDZ serine protease that degrades fibrillar tau, which is associated with Alzheimer disease (AD). +1 more finding

    Full summary, score breakdown and related studies → Original source

  21. 2023-08-22

    Gastrointestinal Dysfunction in Neurological and Neurodegenerative Disorders

    ✓ Peer-reviewed Disease mechanisms Seminars in neurology

    Key finding: Because healthier cognitive phenotypes are observed in individuals with more distinct microbiomes, increased efforts are warranted to develop therapeutic strategies for those at increased risk of developing neurological disorders and patients diagnosed with those disorders.

    Full summary, score breakdown and related studies → Original source

  22. 2023-08-22

    Evaluating the Clinical Significance of Diazepam Binding Inhibitor in Alzheimer's Disease: A Comparison with Inflammatory, Oxidative, and Neurodegenerative Biomarkers

    ✓ Peer-reviewed Tau biomarkers Gerontology

    Key finding: Alzheimer's disease (AD) is one of the pathologies that the scientific world is still desperate for. +3 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2023-08-21

    Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency

    ✓ Peer-reviewed Tau biomarkers Molecular genetics and metabolism reports

    Key finding: Creatine transporter deficiency (CTD) is a rare X-linked disorder of creatine transport caused by pathogenic variants in SLC6A8 (Xq28). +3 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →